MedPath

Sojournix, Inc.

Sojournix, Inc. logo
🇺🇸United States
Ownership
Private
Established
2016-01-01
Employees
11
Market Cap
-
Website
https://sojournixpharma.com

Phase 2 Study of SJX-653 in Postmenopausal Women With Moderate to Severe Vasomotor Symptoms

Phase 2
Terminated
Conditions
Hot Flashes
Interventions
Drug: Placebo
First Posted Date
2020-02-20
Last Posted Date
2022-01-11
Lead Sponsor
Sojournix, Inc.
Target Recruit Count
13
Registration Number
NCT04278872
Locations
🇵🇱

Sojournix Site #403, Lublin, Poland

🇵🇱

Sojournix Site #402, Katowice, Poland

🇵🇱

Sojournix Site #404, Lublin, Poland

and more 19 locations
© Copyright 2025. All Rights Reserved by MedPath